Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Subsidiary Fully Acquires Centrapath Labs for Cash Consideration

Dr. Lal PathLabs announced that its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL), acquired the remaining 30% equity stake in

Dr. Lal PathLabs Subsidiary Fully Acquires Centrapath Labs for Cash Consideration

Dr. Lal PathLabs Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 12:20 am

Dr. Lal PathLabs Subsidiary Fully Acquires Centrapath Labs for Cash Consideration Dr. Lal PathLabs announced that its wholly owned subsidiary, PathLabs Unifiers Private Limited (PUPL), acquired the remaining 30% equity stake in Centrapath Labs Private Limited (CPL) on 13th Oct'26, making CPL a wholly owned subsidiary of PUPL. The cash transaction was completed at INR 1,608.352 per share and is not a related-party transaction. Indore-based CPL operates in healthcare and diagnostic services, reporting turnovers of INR 20.5 crore in FY26, INR 23.7 crore in FY25, and INR 20.8 crore in FY24.

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached 路 11 Nov 2026
  • Attached 路 10 Nov 2026
  • Attached 路 05 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
  • Attached 路 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements